What is propranolol used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Propranolol Used For?

Propranolol is a nonselective beta-adrenergic receptor blocker used primarily for cardiovascular conditions (hypertension, angina, arrhythmias, myocardial infarction), infantile hemangiomas, migraine prophylaxis, essential tremor, anxiety with prominent physical symptoms, hyperthyroidism, and portal hypertension. 1

Primary Cardiovascular Indications

Propranolol's cardiovascular applications stem from its ability to block beta-adrenergic receptors, reducing heart rate, cardiac output, and blood pressure 1:

  • Hypertension: Reduces blood pressure through decreased cardiac output, inhibition of renin release, and diminished sympathetic outflow from the brain 1
  • Angina pectoris: Decreases myocardial oxygen demand by blocking catecholamine-induced increases in heart rate, blood pressure, and myocardial contractility 1, 2
  • Cardiac arrhythmias: Exerts antiarrhythmic effects through beta-blockade and quinidine-like membrane stabilization 1, 2
  • Post-myocardial infarction: Reduces mortality when used after heart attack 3
  • Hypertrophic cardiomyopathy: Controls symptoms related to excessive cardiac contractility 2

Infantile Hemangiomas (First-Line Treatment)

Propranolol is the first-line treatment for proliferating infantile hemangiomas requiring intervention, with an 86-91% response rate. 4

Specific Indications for Treatment 4:

  • Ulcerated hemangiomas: Particularly those causing pain or bleeding
  • Functional impairment:
    • Vision-threatening periocular lesions (can cause amblyopia in up to 80% if untreated) 4
    • Airway obstruction (especially with "beard distribution" lesions) 4
    • Feeding difficulties from lip or nasal lesions 4
  • Risk of disfigurement: Central face, nose, lips, and ear lesions that distort anatomical landmarks 4

Dosing for Infantile Hemangiomas 4:

  • Standard starting dose: 1 mg/kg/day divided into three doses, increased to 2 mg/kg/day after 24 hours
  • High-risk patients (preterm, comorbidities): Start at 0.5 mg/kg/day with inpatient monitoring
  • Treatment duration: Most cases can stop at 12 months of age; majority don't need treatment beyond 17 months 4
  • Response timeline: Color lightening and softening typically occurs within hours to days 4

Neurological and Psychiatric Conditions

  • Migraine prophylaxis: Mechanism unclear but likely involves beta-receptor blockade in pial brain vessels 1, 2, 3
  • Essential tremor: Controls tremor through peripheral beta-blockade 2, 3
  • Performance anxiety: Most effective for physical/somatic symptoms (tremor, palpitations, tachycardia, sweating) rather than cognitive anxiety 5, 6
    • Typical dose: 10-40 mg taken 30-60 minutes before performance 6
    • Not recommended for chronic generalized anxiety disorder 5

Other Established Uses

  • Hyperthyroidism: Controls sympathetic overactivity symptoms (tachycardia, tremor) 2, 7
  • Pheochromocytoma: Manages catecholamine excess (only after alpha-blockade established) 8, 2
  • Portal hypertension: Prevents upper gastrointestinal bleeding in cirrhotic patients 2, 3

Critical Contraindications (Absolute)

Never use propranolol in patients with: 5, 6

  • Second or third-degree heart block
  • Decompensated heart failure or cardiogenic shock
  • Asthma or severe reactive airway disease
  • Sinus bradycardia (HR below normal for age)
  • Active bronchospasm

Essential Pre-Treatment Assessment

Before initiating propranolol, perform 4, 6:

  • Cardiovascular examination: Auscultation for murmurs, peripheral pulse palpation, heart rate and blood pressure measurement
  • ECG indicated if: Abnormal heart rate for age, family history of sudden death/arrhythmia, syncope episodes, maternal connective tissue disease 4
  • Echocardiogram required for: Segmental infantile hemangiomas, heart murmurs, abnormal heart rate 4
  • Screening for: Bronchospasm history, diabetes (propranolol masks hypoglycemia), concurrent cardiac medications 5, 6

Common Pitfalls and Safety Warnings

  • Never abruptly discontinue: Can precipitate rebound hypertension, tachycardia, or angina—always taper gradually 5, 6
  • Hypoglycemia masking: Propranolol blocks adrenergic symptoms of low blood sugar in diabetics; counsel patients accordingly 6, 9
  • Feeding requirement for infants: Must maintain regular feeds to prevent hypoglycemia; stop propranolol if oral intake decreases 4
  • Drug interactions: Avoid combining with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to severe bradycardia risk 5
  • Sleep disturbances: Occur in 2-18.5% of patients, including nightmares and night terrors 9

References

Research

Propranolol.

Profiles of drug substances, excipients, and related methodology, 2017

Research

Propranolol: A 50-Year Historical Perspective.

Annals of Indian Academy of Neurology, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication Transition from Flupentixol/Melitracen to Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propranolol Dosing for Performance Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use and abuse of propranolol.

Canadian family physician Medecin de famille canadien, 1975

Research

Hypertensive response to levonordefrin in a patient receiving propranolol: report of case.

Journal of the American Dental Association (1939), 1988

Guideline

Propranolol and Depression: Mechanism and Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.